首页 | 官方网站   微博 | 高级检索  
     

末梢型肝内胆管细胞癌的诊断及外科治疗效果分析
引用本文:韩少良,王海鹏,徐立斌,王靖,崔修铮,邵永孚.末梢型肝内胆管细胞癌的诊断及外科治疗效果分析[J].中华外科杂志,2001,39(8):590-592.
作者姓名:韩少良  王海鹏  徐立斌  王靖  崔修铮  邵永孚
作者单位:中国医学科学院肿瘤医院腹部外科,
摘    要:目的 探讨末梢型肝内总胆管细胞癌(PIHCC)的诊断及外科治疗结果,以提高其诊治水平。方法 回顾性分析1970-1999年间外科治疗的20例PIHCC患者诊断、治疗及预后的资料。结果 (1)本病缺乏特异性临床表现,部分病例可并发乙型肝炎(35.0%)、肝硬化(45.0%)和血清AFP升高(25.0%);(2)影像学检查:B超、CT、MRI及ECT的诊断率分别为90.0%(18/20)、94.4%(17/18)、3/3及4/3;(3)手术切除率为60%,全组病例的1、3、5年生存率分别为55.0%(11/20)、35.0%(7/20)及20.0%(4/20),其中肝切除术病例分别为83.3%(11/12)、58.3%(7/12)、33.3%(4/12);(4)生存5年以上的4例患者中,直径≤3cm的小肝癌3例、包膜完整的结节型大肝癌1例,且术后均辅助选择性肝动脉灌注化疗,有助于生存率的提高。结论 本病缺乏特异性血清肿瘤标志物,治愈性切除术(包括术后辅助治疗)可获得良好生存率。

关 键 词:肝脏肿瘤  肝切除术  末梢型肝内胆管细胞癌  诊断  PIHCC
修稿时间:2000年8月16日

Diagnosis and surgical treatment of peripheral intrahepatic cholangiocarcinoma
HAN Shaoliang,WANG Haipeng,XU Libin,et al..Diagnosis and surgical treatment of peripheral intrahepatic cholangiocarcinoma[J].Chinese Journal of Surgery,2001,39(8):590-592.
Authors:HAN Shaoliang  WANG Haipeng  XU Libin  
Affiliation:Department of Abdominal Surgery, Tumor Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China.
Abstract:Objective To summarize the experience in diagnosis and surgical treatment of peripheral intrahepatic cholangiocarcinoma (PICC). Methods Clinicopathological features, surgical treatment and prognosis of 20 patients with PICC treated in our hospital from 1970 to 1999 were retrospectively analyzed. Results The patients lacked typical clinical manifestations and some had a history of hepatitis B (35%), cirrhosis (45%), and elevation of serum alpha-fetaprotein (AFP) (25%). The diagnostic rates of ultrasound examination (BUS), CT, MRI and emission computerized tomography (ECT) were 90% (18/20), 94% (17/18), 100% (3/3) and 100% (4/4), respectively. However, the liver lesions detected by these methods needed to be differentiated from hepatocellular carcinoma (HCC), metastatic neoplasm and liver cyst, etc. In all the patients, the resection rate was 60% (12/20) and postoperative overall 1 , 3 and 5 year survival rates were 55% (11/20), 35% (7/12) and 20% (4/20), respectively. The liver resection rates were 83% (11/12), 58% (7/12) and 33% (4/12), respectively. Of the 4 patients who had survived for more than 5 years, 3 had a small liver carcinoma with a diameter less than or equal to 3 cm and one had large nodular liver carcinoma with intact capsule. After operation, all the patients received selective hepatic artery perfusion chemotherapy. Conclusion PICC patients lack specific serum tumor marker can achieve good survival after early detection and curative resection with adjuvant therapies.
Keywords:Liver neoplasm  Surgical resection  Peripheral intrahepatic cholangiocarcinoma
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号